Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP878373.RA-6YF0CxRhcX9EglIOmkWtNX2ZP-BHjESZ4CLU5EiElE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP878373.RA-6YF0CxRhcX9EglIOmkWtNX2ZP-BHjESZ4CLU5EiElE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP878373.RA-6YF0CxRhcX9EglIOmkWtNX2ZP-BHjESZ4CLU5EiElE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP878373.RA-6YF0CxRhcX9EglIOmkWtNX2ZP-BHjESZ4CLU5EiElE130_provenance.
- befree-2016 importedOn "2016-02-19" NP878373.RA-6YF0CxRhcX9EglIOmkWtNX2ZP-BHjESZ4CLU5EiElE130_provenance.
- NP878373.RA-6YF0CxRhcX9EglIOmkWtNX2ZP-BHjESZ4CLU5EiElE130_assertion wasGeneratedBy ECO_0000203 NP878373.RA-6YF0CxRhcX9EglIOmkWtNX2ZP-BHjESZ4CLU5EiElE130_provenance.
- NP878373.RA-6YF0CxRhcX9EglIOmkWtNX2ZP-BHjESZ4CLU5EiElE130_assertion wasDerivedFrom befree-2016 NP878373.RA-6YF0CxRhcX9EglIOmkWtNX2ZP-BHjESZ4CLU5EiElE130_provenance.
- NP878373.RA-6YF0CxRhcX9EglIOmkWtNX2ZP-BHjESZ4CLU5EiElE130_assertion SIO_000772 21389325 NP878373.RA-6YF0CxRhcX9EglIOmkWtNX2ZP-BHjESZ4CLU5EiElE130_provenance.
- NP878373.RA-6YF0CxRhcX9EglIOmkWtNX2ZP-BHjESZ4CLU5EiElE130_assertion evidence source_evidence_literature NP878373.RA-6YF0CxRhcX9EglIOmkWtNX2ZP-BHjESZ4CLU5EiElE130_provenance.
- NP878373.RA-6YF0CxRhcX9EglIOmkWtNX2ZP-BHjESZ4CLU5EiElE130_assertion description "[These observations have resulted in a number of recent clinical trials utilizing IFNα in patients with chronic myeloid leukemia (CML), systemic mast cell disease, hypereosinophilic syndrome and the Philadelphia chromosome-negative myeloproliferative neoplasms (MPN) with promising outcomes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP878373.RA-6YF0CxRhcX9EglIOmkWtNX2ZP-BHjESZ4CLU5EiElE130_provenance.